News
- Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase 2b Trial of NBTX-001 Inhaler for Treatment of Posttraumatic Stress Disorder December 6, 2019
- Nobilis Therapeutics’ NBTX-001 Showed Beneficial Effects in an Animal Model of Autism December 3, 2019
- US Patent is Granted for Nobilis Therapeutics Invention On the Use of Noble Gases to Treat Complications of Pregnancy November 26, 2019
- Nobilis Therapeutics published an article “Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the Literature” in Primary Care Companion For CNS Disorders September 20, 2019
- US Patent Granted for Nobilis Therapeutics Invention Covering the Use of Xenon in ALS August 27, 2019
Recent Posts
- Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase 2b Trial of NBTX-001 Inhaler for Treatment of Posttraumatic Stress Disorder
- Nobilis Therapeutics’ NBTX-001 Showed Beneficial Effects in an Animal Model of Autism
- US Patent is Granted for Nobilis Therapeutics Invention On the Use of Noble Gases to Treat Complications of Pregnancy
- Nobilis Therapeutics published an article “Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the Literature” in Primary Care Companion For CNS Disorders
- US Patent Granted for Nobilis Therapeutics Invention Covering the Use of Xenon in ALS
Recent Comments